TNYA
Tenaya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.67
−0.27%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $800.0K
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.07
- Revenue actual
- $1.1M
- Revenue estimate
- $10.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -40.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.07 | -$0.20 | Miss -192.70% | $1.1M |
| May 6, 2026 | -$0.09 | -$0.09 | In line | $225.0K |
| Mar 11, 2026 | -$0.12 | -$0.12 | Beat 0.91% | — |
| Aug 6, 2025 | -$0.20 | -$0.14 | Beat 30.00% | — |
| Mar 10, 2025 | -$0.31 | -$0.28 | Beat 9.68% | — |
| Mar 18, 2024 | -$0.45 | -$0.40 | Beat 11.11% | $17.7M |
| Mar 8, 2023 | -$0.66 | -$0.61 | Beat 7.58% | — |
| Nov 10, 2022 | -$0.64 | -$0.74 | Miss -15.62% | — |
| Aug 10, 2022 | -$0.75 | -$0.69 | Beat 8.00% | — |
| Mar 23, 2022 | -$0.57 | -$0.63 | Miss -10.53% | — |
| Nov 10, 2021 | -$0.81 | -$0.68 | Beat 16.05% | — |
| Sep 8, 2021 | -$7.17 | -$13 | Miss -84.94% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026